AB1 in Adult Patients with Sickle Cell Disease (SCD)

Clinical trial NCT05261711 · TERMINATED

Trial details

NCT number: NCT05261711
Sponsor: Nirmish Shah
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2022-12-05
Primary completion: 2024-10-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.